JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Pharmaceuticals in Environment and Their Implication in Environmental Health
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Pharmaceuticals in Environment and Their Implication in Environmental Health
Choi, Kyung-Ho; Kim, Pan-Gyi; Park, Jeong-Im;
  PDF(new window)
 Abstract
Pharmaceuticals in the aquatic environment are trace contaminants of growing importance in environmental health due to their physiologically active nature. Pharmaceuticals could affect non-target species and might eventually damage sustainability of susceptible populations in the ecosystem. Potentials for health consequences among susceptible human population cannot be ruled out since long-term exposure to cocktails of pharmaceuticals, which might be present in drinking water, is possible. Selection of antibiotic resistant microorganisms is of another concern. In order to understand, and if needed, to properly address the environmental health issues of pharmaceutical residues, knowledge gaps need to be filled. Knowledge gaps exist in many important areas such as prioritization of target pharmaceuticals for further risk studies, occurrence patterns in different environments, chronic toxicities, and toxicities of pharmaceutical mixtures. Appropriate treatment technologies for drinking water and wastewater could be developed when they are deemed necessary. One of the simplest, yet most efficient measures that could be undertaken is to implement a return program for unused or expired drugs. In addition, implementation of environmental risk assessment frameworks for pharmaceuticals would make it possible to efficiently manage potential environmental health problems associated with pharmaceutical residues in the environment.
 Keywords
pharmaceutical;environment;health;ecosystem;water;
 Language
Korean
 Cited by
1.
부산광역시 주부들의 불용의약품 보관과 처리실태,황병덕;

보건의료산업학회지, 2013. vol.7. 2, pp.69-79 crossref(new window)
2.
낙동강 중류수계에서 의약물질의 분포특성,이순화;정현욱;정진영;민혜주;김보람;박찬갑;오정은;오노 우;사토 노부유키;

대한환경공학회지, 2013. vol.35. 1, pp.45-56 crossref(new window)
3.
온라인 자동화 시료 전처리 및 HR Orbitrap LC/ESI-MS를 이용한 환경시료 중 잔류 의약물질 분석방법 확립,황윤정;신상희;박종숙;

한국물환경학회지, 2013. vol.29. 3, pp.409-419
1.
Characteristics of Occurrence of Pharmaceuticals in the Nakdong River, Journal of Korean Society of Environmental Engineers, 2013, 35, 1, 45  crossref(new windwow)
 References
1.
Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., Buxton, H. T. : Pharmaceu ticals, h ormones, a nd o ther w astewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environmental Science and Technology, 36(6), 1202-1211, 2002 crossref(new window)

2.
Barcel$\'{o}$, D. : Pharmaceutical-residue analysis. Trends in Analytical Chemistry, 26(6), 454-455, 2007 crossref(new window)

3.
Jjemba, P. : Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicology and Environmental Safety, 63(1), 113- 130, 2006 crossref(new window)

4.
Kim, Y. H., Choi, K., Jung, J. Y., Park, S. J., Kim, P. G., Park, J. : Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environment International, 33(3), 370-375, 2007 crossref(new window)

5.
Park, J., Kim, M.-H., Choi, K., Kim, Y., Kim, M.-Y. : Environmental Risk Assessment of Pharmaceutical: Model Application for Estimating Pharmaceutical Exposu res in t he H an R iver Basin. Korea Environment Institute. (KEI 2007 RE-06), 2007

6.
K$\"{u}$mmerer, K. : The presence of pharmaceuticals in the environment due to human use- present knowledge and future challenges. Journal of Environmental Management, 90(8), 2354-2366, 2009 crossref(new window)

7.
Focazio, M. J., Kolpin, D. W., Barnes, K. K., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Barber, L. B., Thurman, M. E. : A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States- II) untreated drinking water sources. The Science of the Total Environment, 402(2-3), 201-216, 2008 crossref(new window)

8.
Bound, J. P., Voulvoulis, N. : Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environmental Health Perspectives 112(12), 1705-1711, 2005 crossref(new window)

9.
Persson, M., Sabelstr$\"{o}$m, E., Gunnarsson, B. : Handling of unused prescription drugs- knowledge, behavior and attitude among Swedish people. Environment International 35(5), 771-774, 2009 crossref(new window)

10.
Kang, Y. H. : Developing Management Policy on Unused/expired Pharmaceuticals. Seoul National University, Master of Public Health thesis, 2006

11.
Kim, Y. H., Jung, J. Y., Park, J., Kim, M. H., Boxall, A. B. A., Choi, K. : Prioritizing veterinary pharmaceuticals for aquatic environment in Korea. Environmental Toxicology and Pharmacology, 26(2), 167-176, 2008 crossref(new window)

12.
Park, J. : Environmental risk management of pharmaceuticals. In: New Challenges and Directions of Environmental Policy, Korea Environment Institute, pp.247-268, 2008

13.
Fent, K., Weston, A. A., Caminada, D. : Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76(2), 122-159, 2006 crossref(new window)

14.
Harries, J. E., Sheahan, D. A., Jobling, S., Matthiessen, P., Neall, P., Sumpter, J. P., Tylor, T., Zaman, N. : Estrogenic activity in five United Kingdom rivers detected by measurement of vitellogenesis in caged male trout. Environmental Toxicology and Chemistry, 16(3), 534-542, 1997 crossref(new window)

15.
Jobling, S., Nolan, M., Tyler, C. R., Brighty, G., Sumpter, J . P. : Ecotoxicology of human pharmaceu -ticals. Environmental Science and Technology, 32(17), 2498-2506, 1998 crossref(new window)

16.
Desbrow, C., Routledge, E. J., Brighty, G. C., Sumpter, J. P., Waldock, M. J. : Identification of estrogenic chemicals in STW effluent 1. Chemical fractionation and in vitro biological screening. Environmental Science and Technology, 32 (11), 1549-1558, 1998 crossref(new window)

17.
Folmar, L. C., Denslow, N. D., Kroll, K., Orlando, E. F., Enblom, J., Marcino, J., Metcalfe, C., Guillette, L. J. Jr. : Altered serum sex steroids and vitellogenin induction in walleye (Stizostedion vitreum) collected near a metropolitan sewage treatment plant. Archives of Environmental Contamination and Toxicology, 40(3), 392-398, 2001 crossref(new window)

18.
Kidd, K. A., Blanchfield, P. J., Mills, K. H., Palace, V. P., Evans, R. E., Lazorchak, J. M., Flick, R. W. : Collapse of a fish population after exposure to a synthetic estrogen. Proceedings of National Academy of Science of the USA 104(21), 8897-8901, 2007 crossref(new window)

19.
Oaks, J. L., Gilbert, M., Virani, M. Z., Watson, R. T., Meteyer, C. U., Rideout, B. A., Shivaprasad, H. L., Ahmed, S., Chaudhry, M. J., Arshad, M., Mahmood, S., Ali, A., Khan, A. A. : Diclofenac residues as the cause of vulture population decline in Pakistan. Nature, 427(6975), 630-603, 2004 crossref(new window)

20.
Proffitt, F., Bagla, P. : Ecology. Circling in on a vulture killer. Science, 306(5694), 223, 2004 crossref(new window)

21.
Naidoo, V., Wolter, K., Cuthbert, R., Duncan, N. : Veterinary diclofenac threatens Africa's endangered vulture species. Regulatory Toxicology and Pharmacology, 53, 205-208, 2009. In press crossref(new window)

22.
Kim, S., Aga, D. S. : Potential ecological and human health impacts of antibiotics and antibiotic-resistant bacteria from wastewater treatment plants. Journal of Toxicology and Environmental Health Part B, 10(8), 559-573, 2007 crossref(new window)

23.
Chung, Y. H. : Occurrence of antimicrobial resistant microbes in Korean environment. 2008 Annual Conference of Korean Society of Environmental Agriculture. 35-40, 2008

24.
Ohlsen, K., Ternes, T., Werner, G., Wallner, U., L$\"{o}$ffler, D., Ziebuhr, W., Witte, W., Hacker, J. : Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage. Environmental Microbiology, 5(8), 711-716, 2003 crossref(new window)

25.
K$\"{u}$mmerer, K., Henninger, A. : Promoting resistance by the emission of antibiotics from hospitals and households into effluent. Clinical Microbiology and Infection, 9(12), 1203-1214, 2003 crossref(new window)

26.
Brandt, K. K., Sj${\o}$holm, O. R., Krogh, K. A., Halling-S${\o}$rensen, B., Nybroe, O. : Increased pollutioninduced bacterial community tolerance to sulfadiazine in soil hotspots amended with artificial root exudates. Environmental Science and Technology, 43(8), 2963-2968, 2009 crossref(new window)

27.
Cattoir, V., Poirel, L., Aubert, C., Soussy, C. J., Nordmann, P. : Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerging Infectious Diseases, 14(2), 231-237, 2008 crossref(new window)

28.
Sapkota, A. R., Curriero, F. C., Gibson, K. E., Schwab, K. J. : Antibiotic-resistant enterococci and fecal i ndicators in su rface w ater a nd g roundwater impacted by a concentrated Swine feeding operation. Environmental Health Perspectives, 115(7), 1040-1045, 2007 crossref(new window)

29.
Yang, H., Dettman, B., Beam, J., Mix, C., Jiang, X. : Occurrence of ceftriaxone-resistant commensal bacteria on a dairy farm and a poultry farm. Canadian Journal of Microbiology, 52(10), 942-950, 2006 crossref(new window)

30.
Martinez, J. L. : Environmental pollution by antibiotics and by antibiotic resistance determinants. Environmental Pollution, 157(11), 2893-2902, 2009 crossref(new window)

31.
Webb, S. T., Ternes, T., Gibert, M., Olejniczak, K. : Indirect human exposure to pharmaceuticqals via drinking water. Toxicology Letters, 142(3) 157-167, 2003 crossref(new window)

32.
Schwab, B. W., Heyes, E. P., Fiori, J. M., Mastrocco, F. J., Roden, N. M., Cragin, D., Meyerhoff, R. D., D'Aco, V. J., Anderson, P. D. : Human pharmaceuticals in U S su rface w aters: A h uman health r isk assessment. Regulatory Toxicology and Pharmacology, 42(3), 296-312, 2005 crossref(new window)

33.
Cunningham, V. L., Binks, S. P., Olson, M. J. : Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regulatory Toxicology and Pharmacology, 53(1), 39-45, 2009 crossref(new window)

34.
Food and Drug Administration : Human Exposure Assessment for Antibiotics in the Water Environment. Seoul National University, 2007

35.
Kim, P. G., Kim, M. Y., Choi, K. H. : Pharmaceutical residues in Han River and their impact on freshwater ecosystem. Report, Korea Research Foundation, 2005

36.
Kim, P. G., Kim, M. Y., Choi, K. H. : Contamination of major veterinary antibiotics and antimicrobials in upstream Han River, and human health and ecological risk assessment. Report, Korea Research Foundation, 2006

37.
Han, G. H., Hur, H. G., Kim, S. D. : Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna. Environmental Toxicology and Chemistry, 25(1), 265-271, 2006 crossref(new window)

38.
Choi, K., Kim, Y. H., Jung, J. Y., Kim, M.-H., Kim, C.-S., Kim, N.-H., Park, J. : Occurrences and ecological risks of roxithromycin, trimethoprim, and chloramphenicol in Han River, Korea. Environmental Toxicology and Chemistry, 27(3), 711-719, 2008 crossref(new window)

39.
National Institute of Environmental Research : Development of analytical method and study of exposure of pharmaceuticals and personal care products in environment. Kyonggi University, Korea Institute of Science and Technology, Interface InfoTech, 2006

40.
National Institute of Environmental Research. : Development of analytical method and study of exposure of pharmaceuticals and personal care products in environment (II). Kyonggi University, Korea Institute of Science and Technology, Interface InfoTech, 2007

41.
National Institute of Environmental Research. : Development of analytical method and study of exposure of pharmaceuticals and personal care products in environment (III). Yongin University, Korea Water Resources Corporation, Seoul Research Institute of Public Health and Environment, 2008

42.
Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., Snyder, S. A. : Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Research, 41(5), 1013-1021, 2007 crossref(new window)

43.
Choi, K., Kim, Y., Park, J., Park, C., Kim, M., Kim, H., Kim, P. : Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Science of the Total Environment, 405(1-3), 120-128, 2008 crossref(new window)

44.
Park, J. : An Approach for Developing Aquatic Environmental Risk Assessment Framework for Pharmaceuticals in Korea. Korea Environment Institute. (KEI 2006 RE-05), 2006

45.
Oh, S. J., Park, J., Lee, M. J., Park, S. Y., Lee, J. H., Choi, K. : Ecological hazard assessment of major veterinary benzimidazoles: acute and chronic toxicities to aquatic microbes and invertebrates. Environmental Toxicology and Chemistry, 25(8), 2221-2226, 2006 crossref(new window)

46.
Calabrese, E. J., Baldwin, L. A. : Toxicology rethinks its central belief. Hormesis demands a reappraisal of the way risks are assessed. Nature, 421(6924), 691-692, 2003 crossref(new window)

47.
US Environmental Protection Agency : Development document for final effluent limitations guidelines and standards for the pharmaceutical manufacturing point source category, Office of Water, EPA-921-R-98-005, 1998

48.
EMEA/CHMP-European Medicines Evaluation Agency/Committee for Medicinal Products for Human Use : Doc. Ref. EMEA/CHMP/SWP/4447/00, Guideline on the Environmental Assessment of Medicinal Products for Human Use, pp. 12, 2006

49.
US Food and Drug Administration. : Guidance for Industry; Environmental Assessment for Human Drug and Biologics Applications, 1998

50.
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to human medicinal products. Official Journal, L 311, 67-128, 2001

51.
Meisel, M. L ., d o Ceu Costa, M., Pena, A. : R egu - latory approach on environmental risk assessment. Risk management recommendations, reasonable and prudent alternatives. Ecotoxicology, 18(8), 1176-1181, 2009 crossref(new window)

52.
Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to veterinary medicinal products. Official Journal, L 311, 1-66, 2001